FDA Brief

Warning letters Drugs

FDA warning letter to

www.d-pharmacy.com

High riskIssued Jul 16, 2025Posted Jul 29, 2025Center for Drug Evaluation and Research (CDER)

FDA warned Singapore website d-pharmacy.com for selling unapproved prescription opioids, benzodiazepines, and stimulants to U.S. consumers.

What happened

FDA reviewed the website www.d-pharmacy.com and found it offering opioids, benzodiazepines, and Schedule II stimulants for sale to U.S. consumers. FDA said these are unapproved new drugs (not FDA-approved for those labeled uses) and misbranded (labeling lacks adequate directions, and prescription drugs are offered without a prescription). There was no inspection; FDA acted on its website review.

What FDA found

  1. FDA says the website sells opioids, benzodiazepines, and stimulants that are not FDA-approved for the labeled uses.

    FD&C Act §§ 301(d), 505(a) [21 U.S.C. §§ 331(d), 355(a)]
  2. FDA says the labeling does not give adequate directions for a layperson to use the prescription drugs safely.

    FD&C Act § 502(f)(1) [21 U.S.C. § 352(f)(1)]
  3. FDA says the site offers prescription drugs for sale without requiring a prescription.

    FD&C Act §§ 503(b)(1), 301(k) [21 U.S.C. §§ 353(b)(1), 331(k)]
  4. FDA says offering these drugs for sale causes misbranded drugs to enter interstate commerce.

    FD&C Act § 301(a) [21 U.S.C. § 331(a)]

What FDA wants

FDA asks www.d-pharmacy.com to stop offering unapproved and misbranded drugs to U.S. consumers. It asks for a written reply within 15 working days describing corrective steps and how recurrence will be prevented.

Who should pay attention

  • U.S. consumers who buy prescription drugs online
  • online pharmacies selling to U.S. customers
  • companies that ship or advertise prescription drugs to U.S. consumers

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Phuoc Loc Tho Herbals, Inc.

    FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.

    High risk
  4. Natuzem

    FDA warned Mexico-based Natuzem for selling unapproved new drugs, including Reumofan Plus, to U.S. consumers online.

    High risk